Parkway Shanghai Hospital notched another project milestone on 16 September as its building structure was completed. The 450-bed multi-specialty hospital is expected to start seeing patients in 2022.
It will offer a comprehensive range of specialties, with a focus on cardiology, cardiac surgery, gastroenterology, urology, minimally invasive surgery, general surgery and internal medicine.
Built on a 35,754 square metre site (about five football fields), Parkway Shanghai is located in close proximity to the Shanghai Hongqiao International Airport and high speed railway station. The hospital will leverage our existing network of medical centres in Shanghai to provide integrated healthcare services for residents in the Yangtze River Delta and beyond.
Located in the medical hub of Shanghai New Hongqiao International Medical Center, Parkway Shanghai will support the Chinese government’s ambition to develop Shanghai into a world-class medical destination that attracts not only Chinese nationals, but also expatriates and medical tourists alike.
The hospital is a joint venture between IHH Healthcare, Taikang Insurance Group and Shanghai Hongxin Medical Investment Holding.
Related Stories
-(6).png?sfvrsn=2b9f1bd5_1)
IHH Singapore Partners Insurers to Champion Colorectal Health
IHH Healthcare Singapore collaborates with leading insurers to promote colorectal health and provide accessible healthcare solutions.
-(8).png?sfvrsn=c74356f2_1)
Gleneagles Hospital Mumbai Brings Quality Liver Care to Indore
Gleneagles Hospital Mumbai teams up with DNS Hospital to provide world-class liver care closer to home for residents in Indore.
Fortis Hospitals Win Prestigious Awards at 12th International Patient Safety Conference
From Data to Action! IHH Malaysia's Game-Changing Approach With New Operations Command Centre
Breaking New Ground as Mount Elizabeth Orchard Unveils Next-Level Diagnostic & Imaging Centre
Advancing Treatment for Pulmonary Arterial Hypertension: An Approach with Sotatercept
A development in Pulmonary Arterial Hypertension (PAH) treatment took place at Mount Elizabeth Hospital, Singapore, where a patient received Sotatercept — a therapy that offers additional possibilities for managing this complex condition. This reflects ongoing progress in cardiology and pulmonary hypertension care.
